A Therapeutic Alternative in the Management of Fibromyalgia
A Therapeutic Alternative in the Management of Fibromyalgia
Barra lateral del artículo
PDF
FLIP
Política de acceso abierto
Esta revista proporciona un acceso abierto a su contenido, teniendo en cuenta el principio de que ofrecer al público un acceso libre a las investigaciones ayuda a un mayor intercambio global del conocimiento y no se hace responsable de los contenidos publicados.
Consideraciones éticas
En sus publicaciones la REC contempla las políticas relacionadas con aspectos éticos que se encuentran en World Associationof Medical Editors (WAME)(http://www.wame.org/about/recommendations-on-publication-ethics-policie)
Política sobre derechos de autor
Los autores que publican en la revista se acogen al código de licencia creative commons 4.0 de atribución no comercial sin derivados y compartir igual.
Contenido principal del artículo
Resumen
Introduction: Fibromyalgia is a condition that affects up to 5% of the population and causes significant deterioration of the quality of life for the sufferer, so it is a therapeutic challenge. The objective of the present study was to describe the experience of the AtlasPROfilax® method in patients with fibromyalgia diagnosed according to the criteria of the American College of Reumatology (ACR) 2010.
Methodology: A cross - sectional study with 63 patients with fibromyalgia was done. Patients were monitored two and six months after applying the AtlasPROfilax® method, in order to evaluate the pain level by visual analogue scale VAS and reevaluate ACR criteria in the follow-up appointment.
Results: The average age of patients was 48.5 SD 12.6 years, 95.24% were female. 100% of patients improved pain (initial VAS of 8 vs 4 and 3 after two and six months respectively) and these were significant results. A reduction of widespread pain index as well as a reduction in the presence of symptoms such as fatigue, non-restorative sleep and cognitive disorders that are typical of fibromyalgia were also found in 46% of cases
Conclusion: This study has provided evidence of the effectiveness of the neuromuscular stimulation method of the suboccipital musculature called AtlasPROfilax® in the treatment of fibromyalgia. Randomized and controlled studies are required to demonstrate the medium and long term effectiveness of this therapeutic alternative.
Descargas
Detalles del artículo
Referencias (VER)
Escudero-Carretero MJ, García-Toyos N, Prieto-Rodríguez MA, Pérez-Corral O, March-Cerdá JC L-DM. Fibromyalgia: Patient perception on their disease and health system. Qualitative research study. Reumatol Clin. 2010;6(1):16–22.
Martin AP, Lanza JRL. Evidences in fibromyalgia. FMC Form Med Contin Aten Prim. 2007;14(8):465–73.
Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M HP. The Fibromyalgia syndrome: Classification, diagnosis, and treatment. Dtsch Arztebl. 2009;106(23):383–91.
Rivera J, Alegre C, Nishishinya MB PC. Therapeutic evidence in fibromyalgia. Reum Clin. 2006;2(SPEC.ISS1):34–7.
Baranowsky J, Klose P, Musial F, Haeuser W, Dobos G LJ. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int. 2009;30(1):1–21.
Sarac AJ GA. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des. 2006;12(1):47–57.
Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(8):743–54.
Patel NB. Guide to Pain Management in Low-Resource Settings.
Matsumoto S, Shimodozono M, Etoh S, Miyata R KK. Effects of thermal therapy combining sauna therapy and underwater exercise in patients with fibromyalgia. Complement Ther Clin Pr. 2010;10(3):201–8.
Saudo Corrales B, Galiano Orea D, Carrasco Pez L, Saxton J DHLM. Autonomous nervous system response and quality of life on women with fibromyalgia after a long-term intervention with physical exercise. Rehabilitación. 2010;44(3):244–9.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Kazt RS, Mease P et al. The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.
Arnold, Lesley M; Stanford, Sharon B; Welge, Jeffrey A; Crofford LJ. Development and testing of the fibromyalgia diagnostic screen for primary care. J Womens Heal. 2012;21(2):231–9.
Segura-Jiménez, Víctor; Aparicio, Virginia A; Álvarez-Gallardo, Inmaculada C; Soriano-Maldonado, Alberto; Estévez-López, Fernando; Delgado-Fernández, Manuel; Carbonell-Baeza A. Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology. 2014;53(10):1803–11.
Carrillo-de-la-Peña, M T; Triñanes, Y; González-Villar, A; Romero-Yuste, S; Gómez-Perretta, C; Arias, M; Wolfe F. Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ). Rheumatol Int. 2015;35(1):141–51.
Bennett, RM; Friend, R; Marcus, D; Bernstein, C; Han, BK; Yachoui, R; Deodhar, A; Kaell A et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res. 2014;66(9):1364–73.
Juan C. Restrepo-Medrano, Elena Ronda-Pérez, Carmen Vives-Cases y DG-G. ¿Qué sabemos sobre los Factores de Riesgo de la Fibromialgia? Rev Salud Publica. 2009;11(4):662–74.
R S. Atlasprofilax. Asociación Latinoamericana de Especialistas en AtlasProfilax. Asociación Latinoamericana de Especialistas en AtlasProfilax. 2011. p. www.atlasprofilax.la.
Navas VEG. Efecto de la terapia Atlasprofilax® sobre los síntomas relacionados con disfunción temporomandibular, bruxismo y la relación de las líneas medias dentales. UstaSalud. 2013;12(2):124–33.
Guymer E LG. Fibromyalgia: Current diagnosis and management. Expert. Rev Clin immunol. 2009;5(2):181–92.
Gómez-Argüelles JM AB. Prevalence of neurological symptoms associated with fibromyalgia. Rev Soc Esp Dolor. 2009;16(4):222–9.
Ware MA, Fitzcharles M-, Joseph L SY. The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial. Anesth Analg. 2010;110(2):604–10.
Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al. Prevalence of fibromyalgia: A survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–53.
A Collado, J Alijotas, P Benito, C Alegre, M Romera, I Sañudo, R Martín, J M Peri, J M Cots, J Maria Peri JMC. Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin. 2002;118(19):745–9.
Downie WW, Leatham P a, Rhind VM, Wright V, Branco J a, Anderson J a. Studies with pain rating scales. Ann Rheum Dis. 1978;37(4):378–81.
A.M. Martín-Nogueras, JIC-A. Efficacy of physiotherapy treatment on pain and quality of life in patients with fibromyalgia. Rehabilitacion. 2012;46(3):199–206.
Workspace.1 NRMA links open the author workspace. O the author workspaceOpens the author workspace1. N and letters correspond to the affiliation list. C to expose these in author workspaceMauricio ÁMA links op. Acupuncture as complementary treatment of fibromyalgya. Rev Colomb Reumatol. 2012;19(1):27–
Jaime Gonzalez Gonzalez, Maria del Mar del Teso Rubio, Carmen Nelida Waliño Paniagua, Juan Jose Criado-Alvarez JSH. Symptomatic pain and fibromyalgia treatment through multidisciplinary approach for Primary Care. Reumatol Clin. 2015;11(1):22–6.
Citaciones
